Single-dose ketamine followed by daily D-cycloserine in treatment-resistant bipolar depression

Journal of Clinical Psychiatry

Volumn 76, Issue 6, 2015, Pages 737-738

  Kantrowitz, Joshua T ^a,b   Halberstam, Batsheva ^a   Gangwisch, James ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; FLUOXETINE PLUS OLANZAPINE; KETAMINE; LURASIDONE; PYRIDOXINE; QUETIAPINE; AMINO ACID RECEPTOR BLOCKING AGENT;

ADULT; BECK DEPRESSION INVENTORY; BIPOLAR DEPRESSION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG APPROVAL; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LETTER; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; ADVERSE EFFECTS; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG COMBINATION; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; CYCLOSERINE; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE; YOUNG ADULT;

EID: 84932626621     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.14l09527     Document Type: Letter

References (16)

1. Zarate CA Jr, Brutsche NE, Ibrahim L, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012;71(11):939-946. doi:10.1016/j.biopsych.2011.12.010 PubMed
2. Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010;67(8):793-802. doi:10.1001/archgenpsychiatry.2010.90 PubMed
3. Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74(4):250-256. doi:10.1016/j.biopsych.2012.06.022 PubMed
4. Epstein IG, Nair KG, Boyd LJ. The treatment of human pulmonary tuberculosis with cycloserine: progress report. Dis Chest. 1956;29(3):241-257.doi:10.1378/chest.29.3.241 PubMed
5. Crane GE. Cycloserine as an antidepressant agent. Am J Psychiatry. 1959;115(11):1025-1026. doi:10.1176/ajp.115.11.1025 PubMed
6. Crane GE. The psychotropic effects of cycloserine: a new use for an antibiotic. Compr Psychiatry. 1961;2(1):51-59. doi:10.1016/S0010-440X(61)80007-2
7. Heresco-Levy U, Gelfin G, Bloch B, et al. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. Int J Neuropsychopharmacol. 2013;16(3):501-506. doi:10.1017/S1461145712000910 PubMed
8. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.1192/bjp.134.4.382 PubMed
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.1136/jnnp.23.1.56 PubMed
10. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7(0):151-169. PubMed
11. Kantrowitz JT, Javitt DC. N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 2010;83(3-4):108-121.doi:10.1016/j.brainresbull.2010.04.006 PubMed
12. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328(8):527-532.doi:10.1056/NEJM199302253280802 PubMed
13. Nathanson E, Gupta R, Huamani P, et al. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis. 2004;8(11):1382-1384. PubMed
14. Törün T, Güngör G, Ozmen I, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9(12):1373-1377. PubMed
15. Hwang TJ, Wares DF, Jafarov A, et al. Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis. Int J Tuberc Lung Dis. 2013;17(10):1257-1266. doi:10.5588/ijtld.12.0863 PubMed
16. Seromycin (cycloserine) [package insert]. West Lafayette, IN: Chao Center; 2009.